The Tej Kohli Cornea Program at Mass. Eye & Ear, a teaching hospital of Harvard Medical School, is a $2m program to accelerate innovative and collaborative research to achieve unprecedented breakthroughs in corneal disease. The Tej Kohli Cornea Program includes cutting-edge molecular technology for the rapid diagnosis of corneal infection, and also GelCORE, an adhesive biomaterial for replacing corneal tissue.
Scientists From Mass. Eye & Ear in Boston Introduce the Tej Kohli Cornea Program
COVID-19 Genetic Vaccine
The Tej Kohli Foundation has provided funding toward a project led by Harvard Medical School scientists at Massachusetts Eye and Ear who are developing a vaccine that uses a harmless virus as a Trojan horse to deliver the genetic sequence of the novel coronavirus into human cells to produce an immune response that could protect people from the disease.